Capricor expands DMD pact with Nippon Shinyaku; AbbVie’s new eye deal

Plus, news about Vigil Neuroscience, AC Immune and Athira Pharma:

Capricor Therapeutics, Nippon Shinyaku expand commercial pact into Europe: The

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

General Catalyst raises $8 billion, with $750 million for health care bets

The venture capital giant General Catalyst has raised $8 billion in fresh capital, with $750 million set aside for health care investments as its acquisition

October 24, 2024

Low-Dose SGLT2 Inhibitor May Protect Kidneys in Youth With T1D

ORLANDO — Adding a low dose of an SGLT2 inhibitor to insulin improved renal function and glycemic control in adolescents with type 1 diabetes (T1D),

June 26, 2024

Marinomed Biotech AG evaluates strategic options for Carragelose portfolio – Biotech Investments

EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company Decision Marinomed Biotech AG evaluates strategic options for Carragelose portfolio 18.12.2023 / 08:33 CET/CEST The issuer

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.